Tenax Therapeutics (TENX) Price/OCF Ratio: History & Chart

Tenax Therapeutics, Inc.(TENX)

Biotechnology · Chapel Hill, NC

$1.92-0.04 (-2.04%)

Delayed quote: Oct 6, 2026, 3:15 PM EDT

About Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinical trials. These compounds are being developed to manage pulmonary hypertension, particularly that linked to heart failure with preserved ejection fraction (HFpEF), as well as other forms of associated pulmonary hypertension. Additionally, the company is progressing TNX-201 (imatinib), a tyrosine kinase inhibitor, designed to treat pulmonary arterial hypertension. Founded in 1967, the organization was initially known as Oxygen Biotherapeutics, Inc. until its rebranding to Tenax Therapeutics, Inc. in September 2014. The company maintains its corporate headquarters in Morrisville, North Carolina.

Chapel Hill, NC

15 employees

www.tenaxthera.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Christopher T. Giordano

View full financials

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Tenax Therapeutics, Inc. (TENX)	$50.93M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.03M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$50.37M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.35M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.51M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$50.28M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$52.05M	2.14	2.08	4.49	3.97
Zhengye Biotechnology Holding Limited (ZYBT)vs ›	$52.13M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$49.58M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$52.28M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

Tenax Therapeutics, Inc. (TENX)

$50.93M

N/A

Eloxx Pharmaceuticals, Inc. (ELOX)vs ›

$51.03M

N/A

Envoy Medical, Inc. (COCH)vs ›

$50.37M

N/A

Clene Inc. (CLNN)vs ›

$50.35M

N/A

eXoZymes, Inc. (EXOZ)vs ›

$51.51M

N/A

Dogwood Therapeutics, Inc. (DWTX)vs ›

$50.28M

N/A

biote Corp. (BTMD)vs ›

$52.05M

2.14

2.08

4.49

3.97

Zhengye Biotechnology Holding Limited (ZYBT)vs ›

$52.13M

N/A

INmune Bio, Inc. (INMB)vs ›

$49.58M

N/A

NOMAD Power Solutions, Inc. (NMAD)vs ›

$52.28M

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio: N/A

TENX Price/OCF Ratio Metrics

TENX Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics